Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

744, PDF, Rheumatoid Arthritis

Disease Control Data, Ankylosing Spondylitis

PDF) Baseline patient characteristics associated with response to

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update

Treating to Target(s) With Interleukin-17 Inhibitors - Charles W

Efficacy of a tight-control and treat-to-target strategy in axial

PDF) Effectiveness of switching between TNF inhibitors in patients

Full article: POSTER PRESENTATIONS

Sex differences in the effectiveness of first-line tumour necrosis

Upadacitinib efficacious in patients with ankylosing spondylitis

Safety Profile, Axial Spondyloarthritis

The Ankylosing Spondylitis Disease Activity Score (ASDAS) is the

The state of the art—psoriatic arthritis outcome assessment in

Canadian Rheumatology Association Meeting Quebec City Convention

Efficacy and Safety of Tofacitinib in Patients with Ankylosing